This page contains a Flash digital edition of a book.
26 ANALYTICAL AND LABORATORY EQUIPMENT


HomoFRET fluorescence polarization


Dr Tobias Pusterla details a novel approach to monitor intracellular hormone packaging


A


berrant secretion of hormones and growth factors is related to


diseases such as diabetes and cancer. Terefore, it is essential to find drugs that interfere with this secretory process. In preparation for the release into the extracellular matrix, molecules are tightly packed into granules. As it is a cellular process that needs to be recorded in a cellular background, common biochemical assays fail to record changes in packaging. A novel approach uses homoFRET fluorescence polarization (FP) for identification of drugs that act on insulin packaging in live cells.


HomoFRET FP detects granular hormone accumulation FP measurements established in high-throughput screenings due to numerous advantages including cost-effectiveness, homogeneity, sensitivity and a huge diversity of applications. During homoFRET FP a


fluorophore excited by polarized light transfers its emission light to a fluorophore of the same type if found in close proximity. Upon energy transfer, the final emission light gets depolarized. Consequently, FP decreases with proximity of the fluorophores. Tis change in FP value can be used to study cellular protein accumulation or dimerization events. Advantages of this


www.scientistlive.com


method are the capability to measure intracellular processes and to monitor the events in real time. Based on homoFRET events,


researchers at North Carolina Central University in the USA developed a cell based assay to measure insulin packaging.1 Te group used rat insulinoma cells (INS-1) that expressed the biosensor: an mCherry-coupled preproinsulin. Whereas discrete mCherry-coupled insulin will not change polarization of the emitted signal, insulin that is tightly packed into granules will transfer energy between mCherry molecules leading to decreased fluorescence polarization (Fig 1.). Te scientists validated


the assay by detecting FP on a Pherastar microplate reader from BMG Labtech. Bafilomycin, an agent that blocks granule formation, was used to modulate insulin packaging. Te unperturbed insulin- producing cells exhibited a low FP value representing granules with densely packed insulin and accordingly high homoFRET. Bafilomycin dose-dependently increased the FP value due to loss of tight packaging. Acceptable Z factors as well as the possibility


120 100 80 60 40 20 0


-20 -40


0 400 800 1200 Well Number


Fig. 2. Pilot screen. Scatter plot of test compounds (circles), hits (asterisks), negative control (red triangle) and positive control (Bafilomycin – blue triangle)


1600 2000


Dr Tobias Pusterla is with BMG Labtech. www.bmglabtech.com


A Free Insulin-mCherry B Insulin-mCherry Granule


Polarized Excitation


High Polarization value


to automate and run the assay in 384 well format proves it suitable for HTS. Tis is underlined by the identification of drugs that act on insulin processing out of 1,782 compounds (Fig. 2). To reliably detect the small changes in FP originating from different packaging states, a microplate reader requires stable measurements. By simultaneously detecting the emission in parallel and perpendicular to the excitation light, the Pherastar FSX not only offers low data variation but also fast read times. Te highly sensitive reader for measuring FP can be easily integrated into robotic systems and its software accelerates data analysis such as calculation of IC50 values.


For more information ✔ at www.scientistlive.com/eurolab Low Polarization value


Fig. 1. HomoFRET fluorescence polarization decreases in granules with tightly packed biosensor


REFERENCE 1


Yi NY et al. (2015),


Development of a Cell- Based Fluorescence Polarization Biosensor Using Preproinsulin to Identify Compounds That Alter Insulin Granule Dynamics. Assay Drug. Dev. Technol. 13(9): 558- 569


% Inhibition


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92